Paper35637952
CBX3 Regulated By YBX1 Promotes Smoking-induced Pancreatic Cancer Progression via Inhibiting SMURF2 Expression.
Zhang H and 9 others. Int J Biol Sci, 2022. Cited by 32 papers, by iCite.
Cite this record
ConductScience Library. CBX3 Regulated By YBX1 Promotes Smoking-induced Pancreatic Cancer Progression via Inhibiting SMURF2 Expression. Papers, record 35637952. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35637952
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- CBX3 Regulated By YBX1 Promotes Smoking-induced Pancreatic Cancer Progression via Inhibiting SMURF2 Expression.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chromosomal Proteins, Non-Histone | Major topic |
| Pancreatic Neoplasms | Major topic |
| Ubiquitin-Protein Ligases | Major topic |
| Y-Box-Binding Protein 1 | Major topic |
| Carcinogenesis | |
| Cell Transformation, Neoplastic | |
| Humans | |
| Smoking |
Source PubMed
References44
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22770212 | Cancer epigenetics: from mechanism to therapy. | Cell | 2012 | https://conductscience.org/library/papers/22770212 | PubMed |
| 2 | 31015415 | Excessive miR-25-3p maturation via N6-methyladenosine stimulated by cigarette smoke promotes pancreatic cancer progression. | Nat Commun | 2019 | https://conductscience.org/library/papers/31015415 | PubMed |
| 3 | 27651444 | Epigenetic Signatures of Cigarette Smoking. | Circ Cardiovasc Genet | 2016 | https://conductscience.org/library/papers/27651444 | PubMed |
| 4 | 28358654 | Cigarette Smoking and Pancreatic Cancer Survival. | J Clin Oncol | 2017 | https://conductscience.org/library/papers/28358654 | PubMed |
| 5 | 33209492 | Expression and prognostic value of Chromobox family members in gastric cancer. | J Gastrointest Oncol | 2020 | https://conductscience.org/library/papers/33209492 | PubMed |
| 6 | 27323854 | Tobacco smoking and methylation of genes related to lung cancer development. | Oncotarget | 2016 | https://conductscience.org/library/papers/27323854 | PubMed |
| 7 | 31669648 | Circ-EZH2 knockdown reverses DDAH1 and CBX3-mediated cell growth and invasion in glioma through miR-1265 sponge activity. | Gene | 2020 | https://conductscience.org/library/papers/31669648 | PubMed |
| 8 | 30481161 | Transcriptional expressions of Chromobox 1/2/3/6/8 as independent indicators for survivals in hepatocellular carcinoma patients. | Aging (Albany NY) | 2018 | https://conductscience.org/library/papers/30481161 | PubMed |
| 9 | 30554637 | Emerging role of noncanonical polycomb repressive complexes in normal and malignant hematopoiesis. | Exp Hematol | 2018 | https://conductscience.org/library/papers/30554637 | PubMed |
| 10 | 31582374 | ID1 Mediates Escape from TGFβ Tumor Suppression in Pancreatic Cancer. | Cancer Discov | 2020 | https://conductscience.org/library/papers/31582374 | PubMed |
| 11 | 18193270 | Tobacco and the risk of pancreatic cancer: a review and meta-analysis. | Langenbecks Arch Surg | 2008 | https://conductscience.org/library/papers/18193270 | PubMed |
| 12 | 26166038 | miR-15b promotes epithelial-mesenchymal transition by inhibiting SMURF2 in pancreatic cancer. | Int J Oncol | 2015 | https://conductscience.org/library/papers/26166038 | PubMed |
| 13 | 7932805 | Cigarette smoking and pancreas cancer: a case-control study based on direct interviews. | J Natl Cancer Inst | 1994 | https://conductscience.org/library/papers/7932805 | PubMed |
| 14 | 25207767 | Pancreatic adenocarcinoma. | N Engl J Med | 2014 | https://conductscience.org/library/papers/25207767 | PubMed |
| 15 | 28638788 | Histone deacetylases, microRNA and leptin crosstalk in pancreatic cancer. | World J Clin Oncol | 2017 | https://conductscience.org/library/papers/28638788 | PubMed |
| 16 | 32937733 | Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4). | Ann Oncol | 2012 | https://conductscience.org/library/papers/32937733 | PubMed |
| 17 | 31581360 | MiR-195 and miR-497 suppress tumorigenesis in lung cancer by inhibiting SMURF2-induced TGF-β receptor I ubiquitination. | Mol Oncol | 2019 | https://conductscience.org/library/papers/31581360 | PubMed |
| 18 | 32894652 | Diverse CBX family members as potential prognostic biomarkers in non-small-cell lung cancer. | FEBS Open Bio | 2020 | https://conductscience.org/library/papers/32894652 | PubMed |
| 19 | 28452926 | KRAS, TP53, CDKN2A, SMAD4, BRCA1, and BRCA2 Mutations in Pancreatic Cancer. | Cancers (Basel) | 2017 | https://conductscience.org/library/papers/28452926 | PubMed |
| 20 | 31912902 | Cancer statistics, 2020. | CA Cancer J Clin | 2020 | https://conductscience.org/library/papers/31912902 | PubMed |
Cited by25
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41683957 | SMURF2 in Anticancer Therapy: Dual Role in Carcinogenesis and Theranostics. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41683957 | PubMed |
| 41681953 | Epigenetic Regulation of Higher-Order Chromatin Structure (HOCS) and Its Implication in Human Diseases. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/41681953 | PubMed |
| 40951838 | Non-coding RNAs as novel biomarkers and therapeutic targets in breast cancer. | Oncol Rev | 2025 | https://conductscience.org/library/papers/40951838 | PubMed |
| 40799245 | YBX1: an RNA/DNA-binding protein that affects disease progression. | Front Oncol | 2025 | https://conductscience.org/library/papers/40799245 | PubMed |
| 40707772 | Long non-coding RNA PRSS23-AS1 as ceRNA promotes breast cancer progression by regulating EMT via miR-3176 /YBX1 axis. | Cancer Gene Ther | 2025 | https://conductscience.org/library/papers/40707772 | PubMed |
| 40519307 | Global, regional, and national burdens of pancreatic cancer attributable to smoking from 1990 to 2021 and the projections to 2035:a systematic analysis from the global burden of disease study 2021. | Front Oncol | 2025 | https://conductscience.org/library/papers/40519307 | PubMed |
| 40347157 | Gender Difference in the Trend and Forecast Analysis of Changes in the Burden of Disease of Pancreatic Cancer Attributable to Smoking in China, 1990-2021. | Cancer Control | 2025 | https://conductscience.org/library/papers/40347157 | PubMed |
| 40089640 | CBX3 promotes multidrug resistance by suppressing ferroptosis in colorectal carcinoma via the CUL3/NRF2/GPX2 axis. | Oncogene | 2025 | https://conductscience.org/library/papers/40089640 | PubMed |
| 40083014 | Epigenetic regulatory protein chromobox family regulates multiple signalling pathways and mechanisms in cancer. | Clin Epigenetics | 2025 | https://conductscience.org/library/papers/40083014 | PubMed |
| 39992162 | miR-379-5p Inhibited the Proliferation of Acute Myeloid Leukemia Cells Through Negative Regulation of YBX1 | Turk J Haematol | 2025 | https://conductscience.org/library/papers/39992162 | PubMed |
| 39990690 | Biological functions of 5-methylcytosine RNA-binding proteins and their potential mechanisms in human cancers. | Front Oncol | 2025 | https://conductscience.org/library/papers/39990690 | PubMed |
| 39934923 | Induction of the p21/CDK6 pathway and alteration of the immune microenvironment by the stem cell marker CBX3 in melanoma. | Stem Cell Res Ther | 2025 | https://conductscience.org/library/papers/39934923 | PubMed |
| 39871432 | Smurf2 Suppresses Proliferation and Cell Cycle of Triple-Negative Breast Cancer Cells by Promoting the Polyubiquitination and Degradation of RPL35A. | J Cell Mol Med | 2025 | https://conductscience.org/library/papers/39871432 | PubMed |
| 39735331 | CBX3 contributes to pancreatic adenocarcinoma progression via promoting KIF20A expression. | Cytotechnology | 2025 | https://conductscience.org/library/papers/39735331 | PubMed |
| 39398252 | RRM2 promotes liver metastasis of pancreatic cancer by stabilizing YBX1 and activating the TGF-beta pathway. | iScience | 2024 | https://conductscience.org/library/papers/39398252 | PubMed |
| 39272883 | Exploring the Role of CBX3 as a Potential Therapeutic Target in Lung Cancer. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39272883 | PubMed |
| 38491348 | The m6A modification mediated-lncRNA POU6F2-AS1 reprograms fatty acid metabolism and facilitates the growth of colorectal cancer via upregulation of FASN. | Mol Cancer | 2024 | https://conductscience.org/library/papers/38491348 | PubMed |
| 38255791 | Y-Box Binding Protein 1: Unraveling the Multifaceted Role in Cancer Development and Therapeutic Potential. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38255791 | PubMed |
| 38182573 | PIWI-interacting RNA-YBX1 inhibits proliferation and metastasis by the MAPK signaling pathway via YBX1 in triple-negative breast cancer. | Cell Death Discov | 2024 | https://conductscience.org/library/papers/38182573 | PubMed |
| 38045198 | Identification and validation of 5-methylcytosine-associated genes in diffuse large B-cell lymphoma. | Heliyon | 2023 | https://conductscience.org/library/papers/38045198 | PubMed |
Genes25
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35637952
GET https://conductscience.org/api/papers/v1/35637952/references?page=2